Neuralgia News and Research

RSS
Neuralgia is pain in one or more nerves that occurs without stimulation of pain receptor (nociceptor) cells. Neuralgia pain is produced by a change in neurological structure or function rather than by the excitation of pain receptors that causes nociceptive pain.
Lovelace Medical Center upgrades to Gamma Knife Perfexion system

Lovelace Medical Center upgrades to Gamma Knife Perfexion system

Top-line results from DURECT's ELADUR Phase II trial in chronic low back pain

Top-line results from DURECT's ELADUR Phase II trial in chronic low back pain

Pitt, UPCI researchers' cancer studies presented at AACR meeting

Pitt, UPCI researchers' cancer studies presented at AACR meeting

Positive results from Neuros Medical Electrical Nerve Block technology study in chronic pain

Positive results from Neuros Medical Electrical Nerve Block technology study in chronic pain

Avanir files IND for NUEDEXTA/AVP-923 Phase II clinical trial for central neuropathic pain in MS patients

Avanir files IND for NUEDEXTA/AVP-923 Phase II clinical trial for central neuropathic pain in MS patients

Mary Ann Liebert to launch new 'Shingles and PHN' open access journal

Mary Ann Liebert to launch new 'Shingles and PHN' open access journal

Researchers identify gene that can predict hypersensitivity to epilepsy drug

Researchers identify gene that can predict hypersensitivity to epilepsy drug

Inhibitex fourth quarter net loss increases to $7.0 million

Inhibitex fourth quarter net loss increases to $7.0 million

Alliqua completes transdermal pain patch initial in vitro study for treatment of PHN

Alliqua completes transdermal pain patch initial in vitro study for treatment of PHN

Depomed completes patient enrollment in Breeze 3 Serada Phase 3 trial to treat menopausal hot flashes

Depomed completes patient enrollment in Breeze 3 Serada Phase 3 trial to treat menopausal hot flashes

Allergan initiates AGN-214868 Phase II trials in post herpetic neuralgia and overactive bladder

Allergan initiates AGN-214868 Phase II trials in post herpetic neuralgia and overactive bladder

Sweden's TLV confirms reimbursement for Qutenza patch for treatment of peripheral neuropathic pain

Sweden's TLV confirms reimbursement for Qutenza patch for treatment of peripheral neuropathic pain

Aestus commences ATx08-001 phase 2 trial to evaluate efficacy of novel pain therapeutic

Aestus commences ATx08-001 phase 2 trial to evaluate efficacy of novel pain therapeutic

Protect Pharma completes sale of two patents and patents-applications to Grunenthal

Protect Pharma completes sale of two patents and patents-applications to Grunenthal

Phase II results of VELCADE in patients with aggressive lymphoma published in Journal of Clinical Oncology

Phase II results of VELCADE in patients with aggressive lymphoma published in Journal of Clinical Oncology

Brain surgeon partners with NASA's JPL to design high-tech surgical instruments

Brain surgeon partners with NASA's JPL to design high-tech surgical instruments

Endo Pharmaceutical partners receive Paragraph IV Certification for generic version of LIDODERM

Endo Pharmaceutical partners receive Paragraph IV Certification for generic version of LIDODERM

FDA approves GRALISE Tablets for treatment of PHN

FDA approves GRALISE Tablets for treatment of PHN

Alliqua completes transdermal pain patch initial study for treatment of PHN

Alliqua completes transdermal pain patch initial study for treatment of PHN

Neuros Medical announces initial feasibility study results of HFAC Nerve Block technology

Neuros Medical announces initial feasibility study results of HFAC Nerve Block technology